CAPTRUST Financial Advisors
AURA icon

CAPTRUST Financial Advisors’s Aura Biosciences AURA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,414
Closed -$243K – 2065
2022
Q3 		$243K Hold
13,414
– – ﹤0.01% 1692
2022
Q2 		$190K Buy
+13,414
New +$222K ﹤0.01% 1728

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CAPTRUST Financial Advisors's AURA Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Aura Biosciences (AURA) in Q4 2022, closing a stake of 13,414 shares — an estimated $243K sold.

CAPTRUST Financial Advisors first reported a position in AURA in Q2 2022 and held it in 2 quarters. The position peaked at $243K in Q3 2022. 49 funds tracked by Wall St. Rank hold AURA as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Aura Biosciences position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 13,414 Aura Biosciences shares in Q4 2022, an estimated $243K.
  • CAPTRUST Financial Advisors first reported a position in Aura Biosciences in Q2 2022 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Aura Biosciences position peaked at $243K in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.